Annett Kreimeyer

Title: Annett Kreimeyer: Innovator in Nucleoside Production

Introduction

Annett Kreimeyer is a notable inventor based in Combs la Ville, France. She has made significant contributions to the field of biochemistry, particularly in the production of nucleosides, which are essential for various pharmaceutical applications. Her work has implications for antiviral, anticancer, and antisense agents.

Latest Patents

Annett Kreimeyer holds a patent for the "Production of 2'-deoxynucleosides and 2'-deoxynucleoside precursors from 2-dehydro-3-deoxy-D-gluconate." This invention relates to a process for preparing 2'-deoxynucleoside compounds or their precursors using 2-dehydro-3-deoxy-D-gluconic acid (KDG) or its salts as a starting material. The variety of 2'-deoxynucleosides and their analogues produced through this method are crucial for synthesis and drug formulation.

Career Highlights

Throughout her career, Annett has worked with several prominent companies, including Rhodia Chimie and Evologic S.A. She has also been associated with Marliere Technologies Societe Civile. Her experience in these organizations has allowed her to refine her expertise in the field of nucleoside production.

Collaborations

Annett Kreimeyer has collaborated with notable professionals in her field, including Volker Dóring and Denis Thibaut. These collaborations have contributed to her innovative work and advancements in nucleoside research.

Conclusion

Annett Kreimeyer's contributions to the field of biochemistry, particularly in nucleoside production, highlight her role as an influential inventor. Her patent and collaborations reflect her commitment to advancing pharmaceutical science.